Clinical Trial Update: VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study [Phase 1]

View source ↗

Summary

Phase 1 feasibility study evaluating the iCoapsys Delivery system for valvular and ventricular improvement in patients with mitral valve regurgitation and left …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Heart Disease
• Left Ventricular Dysfunction
• Mitral Valve Regurgitation

Drugs mentioned

• iCoapsys Delivery System

Snippet

Sponsor: Myocor | Conditions: Mitral Valve Regurgitation, Left Ventricular Dysfunction | Phase 1 | Status: UNKNOWN